(Other OTC:GAMI),(OTC US:GAMI), GREENWICH, Conn., Dec. 22, 2025 (GLOBE NEWSWIRE) — The Gabelli Global Financial Services Fund (GFSIX) has surpassed $100M in assets under management (AUM), reflecting increasing investor participation and strong fund performance. Since its inception in 2018, GFSIX has been managed by Ian Lapey, an experienced portfolio manager who joined Gabelli following a […]

(NASDAQ:BCPC), MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt anti-dumping duties between 90.0 and 115.9% on choline chloride imports from the People's Republic of China. This decision, which will be effective for

HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) — CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of solid tumor cancer, today announced the appointment of Bert W. O'Malley, Jr., MD to its Board of Directors. A physician-scientist by training, Dr. O'Malley brings decades of clinical, academic

MIAMI, Dec. 22, 2025 (GLOBE NEWSWIRE) — RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced its participation in Biotech Showcase 2026, to be held on January 12-14, 2026, in San Francisco, California. Andres Isaias, Chief Executive Officer of RESTEM, will provide presentation on

(TSX:TSL), VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Tree Island Steel Ltd. (the “Company” or “Tree Island Steel“) (TSX: TSL) today announced the addition of Guy Elliott as an independent director joining the Company's board of directors (the “Board“) effective January 1, 2026. Mr. Elliott will also serve as a member of the

(NYSE:CPNG), ATLANTA, Dec. 22, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding Coupang's business, operations, and prospects, including allegations that: (1) Coupang had

Collaboration aims to accelerate the development of treatments for chronic kidney disease (CKD) and other conditions Rectify has developed oral, small molecules that can potentially reduce calcification by enhancing the activity of the ABCC6 protein, a key disease mechanism in CKD BOSTON, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) — Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology

(NYSE:PARR), HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced its 2026 capital expenditure and turnaround outlay guidance with a range of $190 million to $220 million. 2026 Capital Expenditure and Turnaround Outlay Guidance $ in millions Turnarounds 1 $50 – 60 Maintenance & Catalyst 2 105

(PinkSheets:ACRG),(Pinksheets:ACRG), LAS VEGAS, Dec. 22, 2025 (GLOBE NEWSWIRE) — American Clean Resources Group Inc. (OTC: ACRG), a critical minerals processing company focused on domestic supply chain development, today announced the formation of American Clean Energy LLC (ACE), a joint venture to build power infrastructure for data centers and critical mineral processing facilities across the United

DANVERS, MA, Dec. 22, 2025 (GLOBE NEWSWIRE) — DemandScience, a global leader in Precision Performance Marketing, today announced strong performance in the G2 Winter 2026 Reports, earning 26 badges and appearing in 167 reports across account-based orchestration, web and content experiences, advertising, and marketing intelligence categories. In the Winter 2026 Reports, DemandScience earned #1 rankings